Lv3
390 积分 2021-01-26 加入
Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study
1年前
已完结
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
1年前
已完结
LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer
1年前
已完结
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
1年前
已完结
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
1年前
已完结
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
1年前
已完结
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives
1年前
已完结
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial
1年前
已完结
阿奇霉素与阿莫西林联合克拉维酸治疗急性中耳炎患者的临床疗效比较
1年前
已完结
皖公网安备34019202002308
